Home » Biotechnology » Page 4

Tag

Biotechnology

Articles and news on UK and European growth companies operating in the biotechnology sector who are leveraging scientific advancements to innovate in sectors such as healthcare, agriculture, industrial processes, and environmental sustainability.

News

Source BioScience on the rebound

Healthcare and pharmaceutical services provider Source BioScience is mooting acquisitions after turning a £181,000 interim loss into £62,000 pre-tax profits.

News

German biotech sector booming

Germany's biotech sector has continued its strong run in 2008.

News

UCL spin-out Domainex raises £1 million

Domainex, a biopharmaceutical spin-out from University College London (UCL), has raised £1 million to develop its contract research business and commercialise its drug discovery projects.

News

US biotech business floats on AIM

Biopharmaceutical company Medgenics has floated its shares on AIM following a fundraising worth £3.3 million.

News

PLUS admission for biotech firm

Analytical NanoTechnologies, which has developed biochemical monitoring products, has joined PLUS Markets, issuing 22 million shares to give the company a market capitalisation of £7.8 million.

News

OrthoMimetics in £5 million funding

Biotechnology developer OrthoMimetics has raised £5 million in a Series A funding round, managed by Eden Financial.

News

Chameleon BioSurfaces secures funding

Chameleon BioSurfaces, which develops biotechnology for medical device companies, has raised up to £475,000 from an investment syndicate led by London Seed Capital.

News

ValiRx reverses into Azure Holdings

ValiRx, a biopharmaceutical development company, has completed a reverse takeover of AIM company Azure Holdings.

News

Avidex seeking funds

Seed Capital, which runs the four Oxford Technology VCTs, has reduced the valuation of one of its major investments – highly regarded biotech group Avidex.

News

Nordström takes AIM

Swedish entrepreneur Rolf Nordström is poised to float AIM’s first Scandinavian counter, Swedish biotech concern Tri-Pep, to advance an anti-HIV therapy.

Recommended Content